Literature DB >> 10551804

Mannose-dependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53-mediated ER to Golgi trafficking of coagulation factors V and VIII.

M Moussalli1, S W Pipe, H P Hauri, W C Nichols, D Ginsburg, R J Kaufman.   

Abstract

The endoplasmic reticulum-Golgi intermediate compartment (ERGIC) is the site of segregation of secretory proteins for anterograde transport, via packaging into COPII-coated transport vesicles. ERGIC-53 is a homo-hexameric transmembrane lectin localized to the ERGIC that exhibits mannose-selective properties in vitro. Null mutations in ERGIC-53 were recently shown to be responsible for the autosomal recessive bleeding disorder, combined deficiency of coagulation factors V and VIII. We have studied the effect of defective ER to Golgi cycling by ERGIC-53 on the secretion of factors V and VIII. The secretion efficiency of factor V and factor VIII was studied in a tetracycline-inducible HeLa cell line overexpressing a wild-type ERGIC-53 or a cytosolic tail mutant of ERGIC-53 (KKAA) that is unable to exit the ER due to mutation of two COOH-terminal phenylalanine residues to alanines. The results show that efficient trafficking of factors V and VIII requires a functional ERGIC-53 cycling pathway and that this trafficking is dependent on post-translational modification of a specific cluster of asparagine (N)-linked oligosaccharides to a fully glucose-trimmed, mannose9 structure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551804     DOI: 10.1074/jbc.274.46.32539

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Quantitative ER <--> Golgi transport kinetics and protein separation upon Golgi exit revealed by vesicular integral membrane protein 36 dynamics in live cells.

Authors:  T Dahm; J White; S Grill; J Füllekrug; E H Stelzer
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  COPII and the regulation of protein sorting in mammals.

Authors:  Giulia Zanetti; Kanika Bajaj Pahuja; Sean Studer; Soomin Shim; Randy Schekman
Journal:  Nat Cell Biol       Date:  2011-12-22       Impact factor: 28.824

3.  Capturing protein interactions in the secretory pathway of living cells.

Authors:  Beat Nyfeler; Stephen W Michnick; Hans-Peter Hauri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

4.  Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.

Authors:  Bin Zhang; Beth McGee; Jennifer S Yamaoka; Hugo Guglielmone; Katharine A Downes; Salvador Minoldo; Gustavo Jarchum; Flora Peyvandi; Norma B de Bosch; Arlette Ruiz-Saez; Bernard Chatelain; Marian Olpinski; Paula Bockenstedt; Wolfgang Sperl; Randal J Kaufman; William C Nichols; Edward G D Tuddenham; David Ginsburg
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

5.  Advancements in gene transfer-based therapy for hemophilia A.

Authors:  Christopher B Doering; H Trent Spencer
Journal:  Expert Rev Hematol       Date:  2009-12       Impact factor: 2.929

6.  Molecular basis of LMAN1 in coordinating LMAN1-MCFD2 cargo receptor formation and ER-to-Golgi transport of FV/FVIII.

Authors:  Chunlei Zheng; Hui-Hui Liu; Shuguang Yuan; Jiahai Zhou; Bin Zhang
Journal:  Blood       Date:  2010-09-03       Impact factor: 22.113

Review 7.  Recent developments in the understanding of the combined deficiency of FV and FVIII.

Authors:  Bin Zhang
Journal:  Br J Haematol       Date:  2009-01-16       Impact factor: 6.998

8.  Analysis of COPII Vesicles Indicates a Role for the Emp47-Ssp120 Complex in Transport of Cell Surface Glycoproteins.

Authors:  Neil G Margulis; Joshua D Wilson; Christine M Bentivoglio; Nripesh Dhungel; Aaron D Gitler; Charles Barlowe
Journal:  Traffic       Date:  2016-01-10       Impact factor: 6.215

9.  Crystal structure of the legume lectin-like domain of an ERGIC-53-like protein from Entamoeba histolytica.

Authors:  Farha Khan; Kaza Suguna
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-02-21       Impact factor: 1.056

10.  Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.

Authors:  Marcos A Demasi; Erika de S Molina; Christian Bowman-Colin; Fernando H Lojudice; Angelita Muras; Mari C Sogayar
Journal:  Mol Biotechnol       Date:  2016-06       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.